Cita APA

Cuchacovich, M., Soto, L., Edwardes, M., Gutierrez, M., Llanos, C., Pacheco, D., . . . Aguillon, J. (2005). Tumor necrosis factor-alpha-308 g/g promoter polymorphism correlates with a better response to adalimumab in patients with rheumatoid arthritis.

Citación estilo Chicago

Cuchacovich, M., et al. Tumor Necrosis Factor-alpha-308 G/g Promoter Polymorphism Correlates With a Better Response to Adalimumab in Patients With Rheumatoid Arthritis. 2005.

Cita MLA

Cuchacovich, M., et al. Tumor Necrosis Factor-alpha-308 G/g Promoter Polymorphism Correlates With a Better Response to Adalimumab in Patients With Rheumatoid Arthritis. 2005.